Science
On October 18-21st, at the 2009 Annual Meeting of the Society for Leukocyte Biology, International Cytokine Society & International Society for Interferon & Cytokine Research in Lisbon, Portugal, CellerateRX was presented in an abstract titled:
ACTIVATED COLLAGEN ACCELERATES WOUND REPAIR AND MODULATES CYTOKINE PRODUCTION IN WHOLE BLOOD AND PBMC CULTURES. Gregory B. Pott Ph.D., K. Scott Beard M.S., Matthew Regulski D.P.M. and Leland Shapiro M.D.
On July 9-11th, at the 2009 New Cardiovascular Horizons Conference in New Orleans, CellerateRX was featured in a workshop entitled:
Clincal Uses of CellerateRX by Dr. Jane Fore.
On April 26-28, at the Spring 2009 Symposium on Advanced Wound Care in Dallas, TX, CellerateRX was presented in two abstracts, one entitled:
Emerging Use of Topical Biologics in Limb Salvage: The Role of "Activated Collagen" in the Multimodality Treatment.
and the other:
CellerateRX: An Evidence Based Skin Tear Study: Interim Evaluation.
March 19-21, 2009, at the Diabetic Foot Global Conference 2009 (DFCON) in Los Angeles, CA: CellerateRX was presented in an abstract entitled:
Activated Collagen an Evidence Based Study (Interim Data) in Human Leg Ulcers.
Published in the issue of Podiatry Management November/December 2008:
APWCA Case #1: Using Combined Treatment Modalities for Successful Wound Healing.
September 10-13, 2008, at the 9th Annual New Cardiovascular Horizons and Management of the Diabetic Foot & Wound Healing Conference in New Orleans, LA: CellerateRX was highlighted during Dr. Gary Rothenberg's presentation entitled:
Emerging Use of Topical "Biologics" in Limb Salvage: Role of "Activated Collagen" in Multimodality Treatment
April 24-26, 2008, at the Spring 2008 Symposium on Advanced Wound Care in San Diego, CA: CellerateRX was presented in an abstract entitled:
Wound Pain Reduction with Hydrolyzed Collagen.
Published in the issue of Advances in Skin & Wound Care August 2008:
Activated, Type I Collagen (CellerateRX) and Its Effectiveness in Healing Recalcitrant Diabetic Wounds: A Case Presentation.
On October 18-21st, at the 2009 Annual Meeting of the Society for Leukocyte Biology, International Cytokine Society & International Society for Interferon & Cytokine Research in Lisbon, Portugal, CellerateRX was presented in an abstract titled:
ACTIVATED COLLAGEN ACCELERATES WOUND REPAIR AND MODULATES CYTOKINE PRODUCTION IN WHOLE BLOOD AND PBMC CULTURES. Gregory B. Pott Ph.D., K. Scott Beard M.S., Matthew Regulski D.P.M. and Leland Shapiro M.D.
On July 9-11th, at the 2009 New Cardiovascular Horizons Conference in New Orleans, CellerateRX was featured in a workshop entitled:
Clincal Uses of CellerateRX by Dr. Jane Fore.
On April 26-28, at the Spring 2009 Symposium on Advanced Wound Care in Dallas, TX, CellerateRX was presented in two abstracts, one entitled:
Emerging Use of Topical Biologics in Limb Salvage: The Role of "Activated Collagen" in the Multimodality Treatment.
and the other:
CellerateRX: An Evidence Based Skin Tear Study: Interim Evaluation.
March 19-21, 2009, at the Diabetic Foot Global Conference 2009 (DFCON) in Los Angeles, CA: CellerateRX was presented in an abstract entitled:
Activated Collagen an Evidence Based Study (Interim Data) in Human Leg Ulcers.
Published in the issue of Podiatry Management November/December 2008:
APWCA Case #1: Using Combined Treatment Modalities for Successful Wound Healing.
September 10-13, 2008, at the 9th Annual New Cardiovascular Horizons and Management of the Diabetic Foot & Wound Healing Conference in New Orleans, LA: CellerateRX was highlighted during Dr. Gary Rothenberg's presentation entitled:
Emerging Use of Topical "Biologics" in Limb Salvage: Role of "Activated Collagen" in Multimodality Treatment
April 24-26, 2008, at the Spring 2008 Symposium on Advanced Wound Care in San Diego, CA: CellerateRX was presented in an abstract entitled:
Wound Pain Reduction with Hydrolyzed Collagen.
Published in the issue of Advances in Skin & Wound Care August 2008:
Activated, Type I Collagen (CellerateRX) and Its Effectiveness in Healing Recalcitrant Diabetic Wounds: A Case Presentation.
Products & Pipeline
CellerateRX®
